Friedemann Zengerling
Universität Ulm(DE)Klinik und Poliklinik für Urologie(DE)Deutsche Gesellschaft für Urologie(DE)Helmholtz-Institute Ulm(DE)University Hospital Ulm(DE)Technische Hochschule Ulm(DE)
Publications by Year
Research Areas
Testicular diseases and treatments, Bladder and Urothelial Cancer Treatments, Sarcoma Diagnosis and Treatment, Urinary and Genital Oncology Studies, Prostate Cancer Treatment and Research
Most-Cited Works
- → Serum Levels of MicroRNA-371a-3p (M371 Test) as a New Biomarker of Testicular Germ Cell Tumors: Results of a Prospective Multicentric Study(2019)334 cited
- → Membranous NECTIN-4 Expression Frequently Decreases during Metastatic Spread of Urothelial Carcinoma and Is Associated with Enfortumab Vedotin Resistance(2022)192 cited
- → Atezolizumab plus cabozantinib versus cabozantinib monotherapy for patients with renal cell carcinoma after progression with previous immune checkpoint inhibitor treatment (CONTACT-03): a multicentre, randomised, open-label, phase 3 trial(2023)178 cited
- → Primary Results from SAUL, a Multinational Single-arm Safety Study of Atezolizumab Therapy for Locally Advanced or Metastatic Urothelial or Nonurothelial Carcinoma of the Urinary Tract(2019)133 cited
- → NECTIN4 Amplification Is Frequent in Solid Tumors and Predicts Enfortumab Vedotin Response in Metastatic Urothelial Cancer(2024)101 cited